Search hospitals > Texas > Dallas
Parkland Memorial Hospital
Claim this profileDallas, Texas 75235
Global Leader in Cancer
Global Leader in Adenocarcinoma
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Ovarian Cancer
236 reported clinical trials
27 medical researchers
Summary
Parkland Memorial Hospital is a medical facility located in Dallas, Texas. This center is recognized for care of Cancer, Adenocarcinoma, Lung Cancer, Recurrence, Ovarian Cancer and other specialties. Parkland Memorial Hospital is involved with conducting 236 clinical trials across 475 conditions. There are 27 research doctors associated with this hospital, such as David Miller, MD, Suzanne M. Cole, Syed M. Kazmi, and David Gerber, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Adenocarcinoma
Global LeaderStage IV
Stage III
Stage II
Top PIs
David Miller, MDParkland Memorial Hospital1 year of reported clinical research
Expert in Cancer
Studies Ovarian Cancer
20 reported clinical trials
39 drugs studied
Suzanne M. ColeUT Southwestern/Simmons Cancer Center-Dallas3 years of reported clinical research
Expert in Cancer
Studies Bladder Cancer
16 reported clinical trials
38 drugs studied
Syed M. KazmiUT Southwestern/Simmons Cancer Center-Dallas1 year of reported clinical research
Expert in Colorectal Cancer
Studies Colon Cancer
17 reported clinical trials
33 drugs studied
David Gerber, MDUT Southwestern/Simmons Cancer Center-Dallas9 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
9 reported clinical trials
16 drugs studied
Clinical Trials running at Parkland Memorial Hospital
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Colorectal Cancer
Anal Cancer
Squamous Cell Carcinoma
Gallbladder Cancer
Ovarian Tumors
Oropharyngeal Carcinoma
Endocrine + CDK4/6 Inhibitor Therapy
for Breast Cancer
This study is evaluating whether a combination of hormone therapy and a drug that targets cell growth may help treat breast cancer.
Recruiting3 awards Phase 213 criteria
Omitting Radiation Therapy
for Breast Cancer
This study is evaluating whether a type of radiation therapy may help prevent breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Parkland Memorial Hospital?
Parkland Memorial Hospital is a medical facility located in Dallas, Texas. This center is recognized for care of Cancer, Adenocarcinoma, Lung Cancer, Recurrence, Ovarian Cancer and other specialties. Parkland Memorial Hospital is involved with conducting 236 clinical trials across 475 conditions. There are 27 research doctors associated with this hospital, such as David Miller, MD, Suzanne M. Cole, Syed M. Kazmi, and David Gerber, MD.